Kyverna Therapeutics
KYTX
KYTX
94 hedge funds and large institutions have $138M invested in Kyverna Therapeutics in 2024 Q3 according to their latest regulatory filings, with 27 funds opening new positions, 25 increasing their positions, 22 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
8.85% less ownership
Funds ownership: 74.08% → 65.22% (-8.9%)
42% less capital invested
Capital invested by funds: $240M → $138M (-$101M)
90% less call options, than puts
Call options by funds: $7K | Put options by funds: $67K
Holders
94
Holding in Top 10
4
Calls
$7K
Puts
$67K
Top Buyers
| 1 | +$1.62M | |
| 2 | +$1.59M | |
| 3 | +$999K | |
| 4 |
IHAM
Integral Health Asset Management
New York
|
+$978K |
| 5 |
Franklin Resources
San Mateo,
California
|
+$639K |
Top Sellers
| 1 | -$13.9M | |
| 2 | -$5.2M | |
| 3 | -$4.31M | |
| 4 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
-$3.74M |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
-$2.34M |